Although studies on Metabolic Syndrome (MS) have recently been narrowed down to fat over-accumulation, there is no consistency in the obesity requirements for any of the health risk scores and definitions, necessitating more research into the utility of anthropometric measures in predicting cardiometabolic risks in non-obese people. This cross-sectional study looked at the connections and predictabilities of the visceral adiposity index (VAI) and the lipid accumulation product (LAP) for cardiometabolic risks in 174 non-obese persons (91 males and 83 females) aged 35 to 70 who were randomly selected after giving their assent. Weight, height, hip, and waist circumferences were all measured as part of the anthropometric examination. We estimated BMI, waist-height ratio, and waist-hip ratio. Standard laboratory procedures were used to detect serum triglyceride and high density lipoprotein in a 12-hour fasting state (mmol/L). The gender-specific formulae were used to generate the VAI and LAP scores. MABP was computed as DBP + 1/3 Pulse Pressure (mm/Hg) by measuring the systolic and diastolic blood pressures. Significant relationships were found between LAP, VAI, WHTR, WHPR, and BMI (p0.01). In both male and females, multivariate correlations and regression analyses of adiposity and MS characteristics revealed that LAP had a higher influence on MS features and was superior to other adiposity measures (R2: 0.956; p0.01). In conclusion, this study reveals that LAP outperforms conventional measures of adiposity in predicting the risk of lipid and visceral adipose over-accumulation in non-obese people. It was proposed that LAP be used as a risk assessment tool for fat over-accumulation and intervention in non-obese persons.
Please click here : https://journaljammr.com/index.php/JAMMR/article/view/30665
No comments:
Post a Comment